The global market for minimally invasive neurosurgical technologies for intracranial products is expected to hit $3.7 billion by 2015, as outlined by Huntington Beach-based Life Science Intelligence in its Global Neurosurgical Product Markets report. Rapid growth will be seen in stereotactic radiosurgery and neurovascular embolization.
Stereotactic radiosurgery – which treats brain disorders with a high dose of radiation in a one-day session – will be driven by new applications that offer better precision and accuracy, thereby improving patient success rates. The new, more advanced products will expand the amount of patients who can be treated. Upgrades and modules that treat lesions outside the cranium will also increase product sales.
Studies show Irvine's Cortex therapy slows memory loss
Irvine-based Masimo's product revenue jumps 30 percent in 2008
St. Joseph Hospital of Orange gets blue light
UC Irvine researchers study brain link to autism